Winchester, United Kingdom
Exosect Limited is a lean formulations company focused on enabling the efficient, targeted delivery of biological and synthetic active ingredients. Founded in 2001 in the United Kingdom, the company leverages its unique, proprietary technology platforms and extensive formulations know-how to deliver a unique mix of commercial and environmental benefits.
Exosect's business model revolves around out-licensing access to its technology platforms, formulations know-how, and intellectual property to industrial partners, thereby enabling them to grow their business and increase their ROI.
The company secured a significant £1.60M venture round investment on 16 January 2015, with participation from notable investors including Oxford Capital, MTI Ventures, Alpina Partners, and Entrepreneurs Fund.
With a strong focus on biotechnology, Exosect Limited continues to drive innovation in efficient and targeted delivery systems, making it an intriguing prospect for venture capital firms looking to invest in the biotech sector.
